Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Putra Mandiri Jembar Tbk. (PMJS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Putra Mandiri Jembar Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp109 (market cap 1.46T, 537.8K 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 4.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 537.8K). Which is the better fit depends on your goals.

DGNSPMJS
Market Cap
310.75B1.46T
Volume
963.6K537.8K
Lot
9.64K5.38K
Turnover
217.67M57.74M
Average Price
225.89107.37
Value
217.67M57.74M
Indicative Equilibrium Price
226109
Indicative Equilibrium Volume
1K759

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PMJS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Putra Mandiri Jembar Tbk.

PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.

Read more on PMJS